Biolojic Design has announced the appointment of Roger Waltzman as its new Chief Medical Officer (CMO).Waltzman brings significant experience to the role,previously serving as CMO at Indaptus Therapeutics.
This strategic hire underscores Biolojic Design’s commitment to advancing its pipeline and strengthening its leadership team. Waltzman’s expertise will be crucial as the company navigates the complexities of clinical growth and regulatory pathways.
The pharmaceutical and biotechnology industries are experiencing a dynamic period of personnel changes, with companies like Novo Nordisk, Bristol Myers Squibb, and AstraZeneca also making key leadership adjustments. Thes movements reflect the ongoing evolution and competitive landscape within the sector.
For more in-depth coverage of pharmaceutical and biotech industry personnel changes, see STAT+.
Keep reading